Nikki L. Burdett
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Rethinking ovarian cancer III: the past decade and future directions.
Journal: Nature reviews. Cancer
Published: February 23, 2026
Genome doubling fuels ovarian cancer evolution and immune dysregulation.
Journal: Nature
Published: July 16, 2025
Planetary care is good cancer care.
Journal: The Medical journal of Australia
Published: June 19, 2024
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer.
Journal: Nature communications
Published: November 08, 2023
Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer.
Journal: Scientific reports
Published: September 26, 2023
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme.
Journal: Histopathology
Published: November 24, 2022
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer.
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer.
Journal: Nature genetics
Published: November 22, 2021
Bevacizumab prescribing practices for epithelial ovarian cancer in Australia.
Journal: Internal medicine journal
Published: December 20, 2018
Cancer outcomes in patients requiring immunosuppression in addition to corticosteroids for immune-related adverse events after immune checkpoint inhibitor therapy.
Journal: Asia-Pacific journal of clinical oncology
Published: December 05, 2018
Competing Risks in Older Patients With Cancer: A Systematic Review of Geriatric Oncology Trials.
Journal: Journal of the National Cancer Institute
Published: February 19, 2018
Last Updated: 09/26/2026